Gordon Dunn, Chief Financial Officer at Quoin Pharmaceuticals, Ltd. (QNRX), bought 28,856 shares at $0.91 ($23K) on 2024-09-10, disclosed to the SEC on 2024-09-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.78 | 4,000 | $3K | 13.4% |
| 2 | $0.80 | 856 | $685 | 3.0% |
| 3 | $0.80 | 4,000 | $3K | 13.8% |
| 4 | $0.71 | 10,000 | $7K | 30.6% |
| 5 | $0.91 | 10,000 | $9K | 39.2% |
| Total | $0.80 avg | 28,856 |
| $23K |
| 100% |